Transcription of Pharmaceutical regulation: A twelve country study - WHO
{{id}} {{{paragraph}}}
Pharmaceutical regulation: a twelve country study By: Paul G. Ashigbie, MPH candidate 2011, Boston University School of Public Health Supervisor: Dr. Richard Laing, Essential Medicines and Pharmaceutical Policy Department, WHO. [September 2010] (A Pharmaceutical Assessment Management and Policy (PAMP) practicum report) This document should be considered a draft report as not all of the data presented has been officially endorsed by national authorities Page 1 Table of Contents Abbreviations ..3 Executive Introduction ..11 Background ..13 The 2004 level I, 2003 level I and II and the 2007 level I surveys ..14 The 2002 Multi- country study on effective regulation.
Pharmaceutical regulation: A twelve country study Policy (PAMP) practicum report) By: Paul G. Ashigbie, MPH candidate 2011, Boston University School of Public Health
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
IN PHARMACEUTICAL PRICING COUNTRY PROFILE:, In pharmaceutical pricing - country profile: australia, Oecd, In pharmaceutical pricing country profile: australia, Quality Agreement, Profile, Pharmaceutical, Country, COMPANY PROFILE, The Investigational Medicinal Product Dossier, GENERAL GUIDANCE FOR INSPECTORS ON “HOLD, World Health Organization, PharmacoviGilance requirements for BioloGical Products, T-Slot Aluminum Framing Solutions, Parker Hannifin